FIDJI SIMO DEPARTS OPENAI DUE TO CHRONIC ILLNESS

OpenAI’s Fidji Simo is leaving her full-time role as the company’s AGI chief, stepping down to a part-time advisor position after taking medical leave three months ago due to a chronic neuroimmune condition with no cure. Simo, who was most recently the AGI chief after previously serving as CEO of applications, announced the change after realising her recovery would take much longer than expected.

"During that time, it became clear that the road to recovery would be much longer and more complex than I had anticipated—and that I needed to focus on it fully," she wrote in a statement. Simo initially took a few weeks of medical leave in April, shortly after she had assumed the AGI chief title. What began as a short break turned into an extended absence and, ultimately, a permanent change.

you may like

APPLE TAKES TO OPENAI TO COURT FOR POACHING AND STEALING TRADE SECRETS

SALESFORCE BUYS AI STARTUP FOR $3.6BN

STATE DEPARTMENT LAUNCHES $750 FAST-TRACK VISA PILOT

Simo described the dissonance of leading the company’s most forward-looking work while living with a disabling disease. "It has been a jarring experience to spend my days helping build the future while simultaneously navigating a disabling disease that still has no cure," The condition, which she disclosed in April, is a neuroimmune illness that currently has no known cure. She thanked OpenAI’s board, CEO Sam Altman, and President Greg Brockman for their support during the process.

Altman responded publicly on X with a tone of genuine sadness rather than corporate boilerplate. "I am really sad about this and very grateful for all Fidji has done for OpenAI, and even grateful for her friendship and who she is as a person. We all wish her the best for a speedy recovery. This sucks." The message was unusually personal for a CEO commenting on a senior departure, underscoring Simo’s standing at the company.

A ROLE THAT KEPT SHIFTING

At OpenAI, Simo was named CEO of applications. Earlier this year, she was given the additional title of AGI chief, a role focused on the company’s longer-term mission of building artificial general intelligence. That role lasted only a few months before her medical leave intervened.

During her absence, responsibilities were redistributed. President Greg Brockman took charge of product, including leading OpenAI’s super app efforts. On the business side, CSO Jason Kwon, CFO Sarah Friar, and CRO Denise Dresser handled operations. The shift was formalised in a mid-organisation, about a month after Simo’s leave began.

THERE IS A PATTERN TO THIS

Simo’s departure marks another turn in what has been a year of executive churn at OpenAI. Her announcement in April kicked off months of announcements of C-suite changes. COO Brad Lightcap stepped down from his role to focus on special projects. CMO Kate Rouch also stepped down, citing her own health concerns, though she planned to return to a more narrowly scoped role when her condition improved.

The string of departures includes health reasons for Simo and Rouch, while Lightcap moved to special projects. That is unusual for any fast-growing company, much less one at the centre of the AI boom.

what to read next

OPENAI RELEASE NEW MODELS, LIMITS ACCESS AT GOVERNMENTS REQUEST

SAM ALTMAN OFFERS 5% OF OPENAI TO US GOVT

OPENAI HIRES APPLE VISION PRO CHIEF PAUL MEADE. EVERYBODY BREATHE.

WHAT'S NEXT FOR SIMO?

Simo will remain involved as a part-time advisor. Her own message made clear this is not a professional decision but a medical one. The condition that forced her to leave does not have a cure, and her choice to step back rather than try to power through is the sort of honesty that is still rare in Silicon Valley. It is also a reminder that human bodies have limits that no amount of mission-driven urgency can override.